Home > Income Statement > BAL PHARMA

BAL PHARMA
Revenue

    Back to Income Statement
BAL PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹303 Cr₹339 Cr₹304 Cr₹281 Cr₹251 Cr

What is the latest Revenue of BAL PHARMA ?

The latest Revenue ratio of BAL PHARMA is ₹303 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹303 Cr
Mar2024₹339 Cr
Mar2023₹304 Cr
Mar2022₹281 Cr
Mar2021₹251 Cr

How is Revenue of BAL PHARMA Trending?

Years Revenue % Change
Mar2025 ₹303 Cr
-10.65
Mar2024 ₹339 Cr
11.51
Mar2023 ₹304 Cr
8.18
Mar2022 ₹281 Cr
12.25
Mar2021 ₹251 Cr -

Compare Revenue of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹132.6 Cr -3% -4.2% -3.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr NA -3.9% 17.3% Stock Analytics
DIVIS LABORATORIES ₹239,321.0 Cr 5% 21.5% 44.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,924.0 Cr -2.1% -0.2% 34.3% Stock Analytics
CIPLA ₹113,778.0 Cr -2% -2.5% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹99,025.9 Cr 0.4% 4.5% -4.4% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-3%

-4.2%

-3.1%

SENSEX

0.7%

0.8%

-5.1%


You may also like the below Video Courses